Stockreport

Axonics® Announces U.S. Food & Drug Administration Approval of Next Generation Implantable Neurostimulator

Axonics, Inc.  (AXNX) 
Last axonics, inc. earnings: 3/4 04:01 pm Check Earnings Report
PDF New Implantable Neurostimulator Decreases Recharge Interval to Only Once a Month IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc. (NASDAQ: AXNX) [Read more]